Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 76451 - 76475 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Tamibarotene	Investigational	HLA-C	3107	upregulated	tamibarotene results in increased expression of HLA-C mRNA	6p21.33	A24376
Tamibarotene	Investigational	HLA-DMA	3108	upregulated	tamibarotene results in increased expression of HLA-DMA mRNA	6p21.32	A20516
Tamibarotene	Investigational	HLA-DMB	3109	upregulated	tamibarotene results in increased expression of HLA-DMB mRNA	6p21.32	A20516
Tamibarotene	Investigational	HLA-DPA1	3113	upregulated	tamibarotene results in increased expression of HLA-DPA1 mRNA	6p21.32	A20516
Tamibarotene	Investigational	HLA-DQB1	3119	upregulated	tamibarotene results in increased expression of HLA-DQB1 mRNA	6p21.32	A20516
Tamibarotene	Investigational	HLA-DRA	3122	upregulated	tamibarotene results in increased expression of HLA-DRA mRNA	6p21.32	A20516
Tamibarotene	Investigational	HLA-DRB5	3127	upregulated	tamibarotene results in increased expression of HLA-DRB5 mRNA	6p21.32	A20516
Tamibarotene	Investigational	HLA-E	3133	upregulated	tamibarotene results in increased expression of HLA-E mRNA	6p22.1	A24376
Tamibarotene	Investigational	HLA-G	3135	upregulated	tamibarotene results in increased expression of HLA-G mRNA	6p22.1	A24376
Tamibarotene	Investigational	HLA-J	3137	upregulated	tamibarotene results in increased expression of HLA-J mRNA	6p22.1	A24376
Tamibarotene	Investigational	HNRNPA3P1	10151	downregulated	tamibarotene results in decreased expression of HNRNPA3P1 mRNA	10q11.21	A24376
Tamibarotene	Investigational	HPD	3242	upregulated	tamibarotene results in increased expression of HPD mRNA	12q24.31	A24376
Tamibarotene	Investigational	HRASLS2	54979	upregulated	tamibarotene results in increased expression of HRASLS2 mRNA	11q12.3	A20516
Tamibarotene	Investigational	HSP90B1	7184	downregulated	tamibarotene results in decreased expression of HSP90B1 mRNA	12q23.3	A24376
Tamibarotene	Investigational	ICAM3	3385	upregulated	tamibarotene results in increased expression of ICAM3 mRNA	19p13.2	A24376
Tamibarotene	Investigational	IER3	8870	upregulated	tamibarotene results in increased expression of IER3 mRNA	6p21.33	A24376
Tamibarotene	Investigational	IFI16	3428	upregulated	tamibarotene results in increased expression of IFI16 mRNA	1q23.1	A24376
Tamibarotene	Investigational	IFI35	3430	upregulated	tamibarotene results in increased expression of IFI35 mRNA	17q21.31	A24376
Tamibarotene	Investigational	IFIT3	3437	upregulated	tamibarotene results in increased expression of IFIT3 mRNA	10q23.31	A24376
Tamibarotene	Investigational	IGFBP3	3486	upregulated	tamibarotene results in increased expression of IGFBP3 mRNA	7p12.3	A24379
Tamibarotene	Investigational	IGKV1OR2-118	339562	downregulated	tamibarotene results in decreased expression of IGKV1OR2-118 mRNA	2p11.2	A24376
Tamibarotene	Investigational	IL10RB	3588	upregulated	tamibarotene results in increased expression of IL10RB mRNA	21q22.11	A24376
Tamibarotene	Investigational	IL1B	3553	upregulated	tamibarotene results in increased expression of IL1B mRNA	2q14.1	A24376
Tamibarotene	Investigational	IL6	3569	downregulated	tamibarotene results in decreased expression of IL6 mRNA	7p15.3	A20516
Tamibarotene	Investigational	ILF3	3609	downregulated	tamibarotene results in decreased expression of ILF3 mRNA	19p13.2	A24376

Displaying entries 76451 - 76475 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability